Transfer RNA fragments replace microRNA regulators of the cholinergic post-stroke immune blockade
Authors:
- Katarzyna WinekKWKatarzyna Winek
- Sebastian LobentanzerSLSebastian Lobentanzer
- Bettina NadorpBNBettina Nadorp
- Serafima DubnovSDSerafima Dubnov
- Claudia DamesCDClaudia Dames
- Gilli MoshitzkyGMGilli Moshitzky
- Benjamin HotterBHBenjamin Hotter
- Christian MeiselCMChristian Meisel
- David S GreenbergDGDavid S Greenberg
- Sagiv ShifmanSSSagiv Shifman
- Jochen KleinJKJochen Klein
- Shani Shenhar-TsarfatySSShani Shenhar-Tsarfaty
Preprint
Abstract
Stroke is a leading cause of death and disability. Recovery depends on balance between inflammatory response and immune suppression, which can be CNS-protective but may worsen prognosis by increasing patients’ susceptibility to infections. Peripheral cholinergic blockade of immune reactions fine-tunes this immune response, but its molecular regulators are unknown. Therefore, we sought small RNA balancers of the cholinergic anti-inflammatory pathway in peripheral blood from ischemic stroke patients. Using RNA-sequencing and RT-qPCR, we discovered in patients’ blood on day 2 after stroke a “change of guards” reflected in massive decreases in microRNAs (miRs) and increases in transfer RNA fragments (tRFs) targeting cholinergic transcripts. Electrophoresis-based size-selection followed by RT-qPCR validated the top 6 upregulated tRFs in a separate cohort of stroke patients, and independent small RNA-sequencing datasets presented post-stroke enriched tRFs as originating from lymphocytes and monocytes. In these immune compartments, we found CD14+ monocytes to express the highest amounts of cholinergic transcripts. In-depth analysis of CD14+ regulatory circuits revealed minimally overlapping subsets of transcription factors carrying complementary motifs to miRs or tRFs, indicating different roles for the stroke-perturbed members of these small RNA species. Furthermore, LPS-stimulated murine RAW264.7 cells presented dexamethasone-suppressible upregulation of the top 6 tRFs identified in human patients, indicating an evolutionarily conserved and pharmaceutically treatable tRF response to inflammatory cues. Our findings identify tRF/miR subgroups which may co-modulate the homeostatic response to stroke in patients’ blood and open novel venues for establishing RNA-targeted concepts for post-stroke diagnosis and therapeutics.Keywords
All Related Versions
- Published version: Proceedings of the National Academy of Sciences, 117 (51), 32606.
This publication has 50 references indexed in Scilit:
- Blood microRNAs in Low or No Risk Ischemic Stroke PatientsInternational Journal of Molecular Sciences, 2013
- A miRNA-tRNA mix-up: tRNA origin of proposed miRNARNA Biology, 2010
- miRExpress: Analyzing high-throughput sequencing data for profiling microRNA expressionBMC Bioinformatics, 2009
- Angiogenin cleaves tRNA and promotes stress-induced translational repressionJournal of Cell Biology, 2009
- Monocyte Subtypes Predict Clinical Course and Prognosis in Human StrokeJournal of Cerebral Blood Flow & Metabolism, 2009
- The Kinetic Change of the Serum Angiogenin Level in Patients with Acute Cerebral InfarctionEuropean Neurology, 2007
- The Kruppel‐like factor KLF4 is a critical regulator of monocyte differentiationThe EMBO Journal, 2007
- Stroke-Induced ImmunodepressionStroke, 2007
- Kruppel-like Factor 4 Is a Mediator of Proinflammatory Signaling in MacrophagesJournal of Biological Chemistry, 2005
- Central nervous system injury-induced immune deficiency syndromeNature Reviews Neuroscience, 2005